Photodynamic therapy with oral administration of 5-aminolevulinic acid for the treatment of skin cancers and hair follicle sebaceous glands tumors
Not Applicable
Recruiting
- Conditions
- Skin cancers and hair follicle sebaceous glands tumors
- Registration Number
- JPRN-UMIN000007523
- Lead Sponsor
- Department of Plastic and Reconstructive Surgery, Osaka City University, Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who meet any of the conditions described below are excluded. 1. Patients with hypersensitivity to 5-ALA or porphyrins. 2. In case of known or suspected pregnancy, or women who are breast-feeding. 3.In case of known or suspected acute or chronic types of porphyria. 4. In case of renal insufficiency (serum creatinine is more than 2.0mg/dl) 5. In case of hepatic insufficiency (serum gamma glutamyl transpeptidase >100IU/l, ptotronbin time <60% or total bilirubin >3mg/dl) 6. In case of other conditions considered as undesirable for entry in this clinical trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy of photodynamic therapy with oral administration of 5-aminolevulinic acid
- Secondary Outcome Measures
Name Time Method